Drug
Skin Protectant
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Macular Degeneration | 460 | 273.0 | 320.6 | signal |
| 2 | Vaginal Discharge | 148 | 101.6 | 106.7 | signal |
| 3 | Paraesthesia Oral | 198 | 94.9 | 101.4 | signal |
| 4 | Oral Candidiasis | 149 | 78.7 | 82.7 | signal |
| 5 | Procedural Pain | 190 | 47.0 | 50.0 | signal |
| 6 | Frequent Bowel Movements | 152 | 38.6 | 40.6 | signal |
| 7 | Colitis | 160 | 29.0 | 30.5 | signal |
| 8 | Rectal Haemorrhage | 162 | 25.6 | 27.0 | signal |
| 9 | Colitis Ulcerative | 153 | 23.4 | 24.6 | signal |
| 10 | Therapeutic Product Effect Incomplete | 222 | 21.4 | 23.0 | signal |
| 11 | Infusion Related Reaction | 206 | 21.3 | 22.7 | signal |
| 12 | Haematochezia | 171 | 21.2 | 22.3 | signal |
| 13 | Accident | 36 | 20.6 | 20.8 | signal |
| 14 | Nephropathy | 26 | 18.9 | 19.0 | signal |
| 15 | Body Height Decreased | 25 | 15.8 | 15.9 | signal |
| 16 | Haemorrhoids | 43 | 15.0 | 15.2 | signal |
| 17 | Dyspepsia | 210 | 14.6 | 15.6 | signal |
| 18 | Body Temperature Increased | 42 | 14.0 | 14.1 | signal |
| 19 | Schizophrenia | 23 | 12.9 | 13.0 | signal |
| 20 | Bacteraemia | 21 | 12.1 | 12.2 | signal |
| 21 | Sciatica | 28 | 12.0 | 12.1 | signal |
| 22 | Obesity | 28 | 11.9 | 12.0 | signal |
| 23 | Joint Range Of Motion Decreased | 23 | 11.7 | 11.8 | signal |
| 24 | Malnutrition | 19 | 11.6 | 11.7 | signal |
| 25 | Febrile Neutropenia | 113 | 11.6 | 12.0 | signal |
| 26 | Pneumonia Aspiration | 42 | 11.5 | 11.6 | signal |
| 27 | Disseminated Intravascular Coagulation | 23 | 11.1 | 11.2 | signal |
| 28 | Cholelithiasis | 51 | 10.6 | 10.7 | signal |
| 29 | Hepatic Steatosis | 28 | 10.2 | 10.3 | signal |
| 30 | Synovitis | 25 | 9.4 | 9.5 | signal |
| 31 | Blood Bilirubin Increased | 37 | 9.3 | 9.4 | signal |
| 32 | Drug Eruption | 24 | 9.3 | 9.3 | signal |
| 33 | Foot Deformity | 15 | 9.2 | 9.2 | signal |
| 34 | Hepatotoxicity | 29 | 8.9 | 9.0 | signal |
| 35 | Ileus | 16 | 8.8 | 8.9 | signal |
| 36 | Limb Injury | 34 | 8.5 | 8.6 | signal |
| 37 | Anaemia | 237 | 8.5 | 9.1 | signal |
| 38 | Knee Arthroplasty | 24 | 7.8 | 7.9 | signal |
| 39 | Pyrexia | 397 | 7.8 | 8.8 | signal |
| 40 | Constipation | 238 | 7.5 | 8.0 | signal |
| 41 | Abdominal Pain | 243 | 7.1 | 7.6 | signal |
| 42 | Device Related Infection | 16 | 7.1 | 7.1 | signal |
| 43 | Clostridium Difficile Colitis | 11 | 7.0 | 7.1 | signal |
| 44 | Atelectasis | 10 | 7.0 | 7.0 | signal |
| 45 | Dermatitis | 21 | 6.9 | 6.9 | signal |
| 46 | Movement Disorder | 32 | 6.7 | 6.8 | signal |
| 47 | Joint Stiffness | 26 | 6.7 | 6.8 | signal |
| 48 | Arthropathy | 55 | 6.7 | 6.8 | signal |
| 49 | Septic Shock | 42 | 6.6 | 6.7 | signal |
| 50 | Electrolyte Imbalance | 11 | 6.5 | 6.5 | signal |
| 51 | Dysstasia | 28 | 6.5 | 6.6 | signal |
| 52 | Weight Decreased | 266 | 6.5 | 7.0 | signal |
| 53 | Erythema | 190 | 6.3 | 6.6 | signal |
| 54 | Covid-19 Pneumonia | 11 | 6.3 | 6.3 | signal |
| 55 | Hypoxia | 32 | 6.2 | 6.3 | signal |
| 56 | Skin Infection | 10 | 6.1 | 6.1 | signal |
| 57 | Iron Deficiency Anaemia | 8 | 5.9 | 5.9 | signal |
| 58 | Hepatic Enzyme Increased | 58 | 5.8 | 5.9 | signal |
| 59 | Arteriosclerosis | 8 | 5.8 | 5.8 | signal |
| 60 | Hepatic Function Abnormal | 31 | 5.7 | 5.7 | signal |
| 61 | Blood Lactate Dehydrogenase Increased | 13 | 5.5 | 5.6 | signal |
| 62 | Liver Disorder | 36 | 5.5 | 5.6 | signal |
| 63 | Skin Disorder | 27 | 5.5 | 5.6 | signal |
| 64 | Osteoporosis | 33 | 5.4 | 5.5 | signal |
| 65 | Scab | 9 | 5.4 | 5.4 | signal |
| 66 | Lymphocyte Count Decreased | 14 | 5.4 | 5.4 | signal |
| 67 | Cytokine Release Syndrome | 15 | 5.4 | 5.4 | signal |
| 68 | Lower Respiratory Tract Infection | 35 | 5.3 | 5.3 | signal |
| 69 | Bone Density Decreased | 24 | 5.2 | 5.2 | signal |
| 70 | Gastroenteritis | 11 | 5.1 | 5.1 | signal |
| 71 | Respiratory Failure | 55 | 5.1 | 5.2 | signal |
| 72 | Osteoarthritis | 32 | 5.1 | 5.2 | signal |
| 73 | Adrenal Insufficiency | 9 | 5.1 | 5.1 | signal |
| 74 | Erythema Multiforme | 7 | 5.1 | 5.1 | signal |
| 75 | Hepatic Encephalopathy | 7 | 5.1 | 5.1 | signal |
| 76 | Sepsis | 82 | 5.0 | 5.1 | signal |
| 77 | Supraventricular Tachycardia | 7 | 5.0 | 5.0 | signal |
| 78 | Oesophagitis | 8 | 5.0 | 5.0 | signal |
| 79 | Hypercalcaemia | 9 | 5.0 | 5.0 | signal |
| 80 | Pleural Effusion | 44 | 4.9 | 5.0 | signal |
| 81 | Psoriatic Arthropathy | 29 | 4.9 | 4.9 | signal |
| 82 | Hypokalaemia | 33 | 4.9 | 4.9 | signal |
| 83 | Stevens-johnson Syndrome | 16 | 4.9 | 4.9 | signal |
| 84 | Renal Tubular Necrosis | 7 | 4.8 | 4.8 | signal |
| 85 | Psychotic Disorder | 21 | 4.8 | 4.9 | signal |
| 86 | Malaise | 311 | 4.8 | 5.2 | signal |
| 87 | Dermatitis Contact | 8 | 4.8 | 4.8 | signal |
| 88 | Pneumothorax | 11 | 4.7 | 4.7 | signal |
| 89 | Neutrophil Count Decreased | 28 | 4.7 | 4.7 | signal |
| 90 | Respiratory Distress | 19 | 4.7 | 4.7 | signal |
| 91 | Hyperkalaemia | 24 | 4.7 | 4.7 | signal |
| 92 | Gastritis | 18 | 4.7 | 4.7 | signal |
| 93 | Palmar-plantar Erythrodysaesthesia Syndrome | 16 | 4.7 | 4.7 | signal |
| 94 | Cellulitis | 34 | 4.6 | 4.6 | signal |
| 95 | Metastases To Bone | 11 | 4.6 | 4.6 | signal |
| 96 | Interstitial Lung Disease | 31 | 4.4 | 4.4 | signal |
| 97 | Delirium | 22 | 4.3 | 4.4 | signal |
| 98 | Neutropenia | 85 | 4.3 | 4.4 | signal |
| 99 | Obstructive Airways Disorder | 7 | 4.3 | 4.3 | signal |
| 100 | Oral Pain | 14 | 4.2 | 4.3 | signal |
| 101 | Blood Potassium Increased | 10 | 4.2 | 4.2 | signal |
| 102 | Ascites | 18 | 4.2 | 4.2 | signal |
| 103 | Bedridden | 8 | 4.1 | 4.2 | signal |
| 104 | Pericardial Effusion | 14 | 4.1 | 4.2 | signal |
| 105 | Lung Neoplasm Malignant | 25 | 4.1 | 4.1 | signal |
| 106 | C-reactive Protein Increased | 22 | 4.1 | 4.1 | signal |
| 107 | Pulmonary Congestion | 8 | 4.1 | 4.1 | signal |
| 108 | Alanine Aminotransferase Increased | 37 | 4.1 | 4.1 | signal |
| 109 | Candida Infection | 10 | 4.1 | 4.1 | signal |
| 110 | Conjunctivitis | 11 | 4.1 | 4.1 | signal |
| 111 | Therapy Partial Responder | 9 | 4.1 | 4.1 | signal |
| 112 | Chronic Obstructive Pulmonary Disease | 31 | 4.0 | 4.1 | signal |
| 113 | Toxic Skin Eruption | 6 | 4.0 | 4.0 | signal |
| 114 | Hypophagia | 15 | 4.0 | 4.0 | signal |
| 115 | Tachypnoea | 8 | 4.0 | 4.0 | signal |
| 116 | Diabetes Mellitus | 45 | 4.0 | 4.0 | signal |
| 117 | Hyponatraemia | 33 | 4.0 | 4.0 | signal |
| 118 | Musculoskeletal Pain | 31 | 4.0 | 4.0 | signal |
| 119 | Gamma-glutamyltransferase Increased | 13 | 4.0 | 4.0 | signal |
| 120 | Acute Myeloid Leukaemia | 9 | 3.9 | 3.9 | signal |
| 121 | Gastrooesophageal Reflux Disease | 46 | 3.9 | 3.9 | signal |
| 122 | Urinary Retention | 19 | 3.9 | 3.9 | signal |
| 123 | Transfusion | 6 | 3.9 | 3.9 | signal |
| 124 | Hepatic Failure | 17 | 3.8 | 3.8 | signal |
| 125 | Pneumonitis | 15 | 3.8 | 3.8 | signal |
| 126 | Prescribed Underdose | 11 | 3.7 | 3.8 | signal |
| 127 | Flatulence | 31 | 3.7 | 3.8 | signal |
| 128 | Gastrointestinal Pain | 6 | 3.7 | 3.7 | signal |
| 129 | Red Blood Cell Sedimentation Rate Increased | 6 | 3.7 | 3.7 | signal |
| 130 | Bone Marrow Failure | 11 | 3.7 | 3.7 | signal |
| 131 | Cerebral Infarction | 13 | 3.6 | 3.6 | signal |
| 132 | Toxic Epidermal Necrolysis | 8 | 3.6 | 3.6 | signal |
| 133 | Skin Fissures | 10 | 3.6 | 3.6 | signal |
| 134 | Spinal Disorder | 5 | 3.6 | 3.6 | signal |
| 135 | Haematuria | 18 | 3.6 | 3.6 | signal |
| 136 | Wheezing | 31 | 3.6 | 3.6 | signal |
| 137 | Eating Disorder | 11 | 3.5 | 3.5 | signal |
| 138 | Pulmonary Oedema | 23 | 3.5 | 3.5 | signal |
| 139 | Pain | 315 | 3.5 | 3.8 | signal |
| 140 | Decreased Immune Responsiveness | 5 | 3.5 | 3.5 | signal |
| 141 | Product Administration Error | 10 | 3.4 | 3.4 | signal |
| 142 | Haemoptysis | 14 | 3.4 | 3.4 | signal |
| 143 | Pneumocystis Jirovecii Pneumonia | 5 | 3.4 | 3.4 | signal |
| 144 | Mucosal Inflammation | 13 | 3.4 | 3.4 | signal |
| 145 | Platelet Count Decreased | 53 | 3.4 | 3.4 | signal |
| 146 | Emphysema | 5 | 3.4 | 3.4 | signal |
| 147 | Inappropriate Antidiuretic Hormone Secretion | 5 | 3.3 | 3.3 | signal |
| 148 | Subarachnoid Haemorrhage | 5 | 3.3 | 3.3 | signal |
| 149 | Subdural Haematoma | 7 | 3.3 | 3.3 | signal |
| 150 | Poor Venous Access | 5 | 3.3 | 3.3 | signal |
| 151 | Proteinuria | 9 | 3.2 | 3.3 | signal |
| 152 | Immunodeficiency | 7 | 3.2 | 3.2 | signal |
| 153 | Eructation | 9 | 3.2 | 3.2 | signal |
| 154 | Dementia | 13 | 3.2 | 3.2 | signal |
| 155 | Tooth Infection | 6 | 3.1 | 3.1 | signal |
| 156 | International Normalised Ratio Increased | 13 | 3.1 | 3.1 | signal |
| 157 | Intentional Product Misuse | 39 | 3.1 | 3.1 | signal |
| 158 | Pancreatitis Acute | 10 | 3.0 | 3.1 | signal |
| 159 | Blood Creatine Phosphokinase Increased | 13 | 3.0 | 3.0 | signal |
| 160 | Cyanosis | 7 | 3.0 | 3.0 | signal |
| 161 | Acute Hepatic Failure | 6 | 3.0 | 3.0 | signal |
| 162 | Shock | 10 | 3.0 | 3.0 | signal |
| 163 | Herpes Zoster | 25 | 3.0 | 3.0 | signal |
| 164 | Drug Reaction With Eosinophilia And Systemic Symptoms | 11 | 2.9 | 2.9 | signal |
| 165 | Anaphylactic Shock | 11 | 2.9 | 2.9 | signal |
| 166 | Blood Test Abnormal | 6 | 2.9 | 2.9 | signal |
| 167 | Drug Ineffective | 559 | 2.9 | 3.3 | signal |
| 168 | Posterior Reversible Encephalopathy Syndrome | 4 | 2.9 | 2.9 | no signal |
| 169 | Blood Urine Present | 8 | 2.9 | 2.9 | signal |
| 170 | Cytopenia | 5 | 2.8 | 2.8 | signal |
| 171 | Altered State Of Consciousness | 9 | 2.8 | 2.8 | signal |
| 172 | Impaired Quality Of Life | 6 | 2.8 | 2.8 | signal |
| 173 | Melaena | 9 | 2.8 | 2.8 | signal |
| 174 | Tooth Extraction | 5 | 2.7 | 2.7 | no signal |
| 175 | Hypothermia | 4 | 2.7 | 2.7 | no signal |
| 176 | Sluggishness | 4 | 2.7 | 2.7 | no signal |
| 177 | Hypoglycaemia | 19 | 2.7 | 2.7 | signal |
| 178 | Sars-cov-2 Test Positive | 5 | 2.5 | 2.5 | no signal |
| 179 | Breast Cancer Metastatic | 4 | 2.5 | 2.5 | no signal |
| 180 | Serotonin Syndrome | 7 | 2.5 | 2.5 | signal |
| 181 | Cerebral Haemorrhage | 13 | 2.5 | 2.5 | signal |
| 182 | Cytomegalovirus Infection | 6 | 2.5 | 2.5 | no signal |
| 183 | Status Epilepticus | 4 | 2.4 | 2.4 | no signal |
| 184 | Internal Haemorrhage | 4 | 2.4 | 2.4 | no signal |
| 185 | Drug Abuse | 29 | 2.4 | 2.4 | signal |
| 186 | Metastases To Lung | 4 | 2.4 | 2.4 | no signal |
| 187 | Gastric Haemorrhage | 4 | 2.3 | 2.3 | no signal |
| 188 | Peritonitis | 7 | 2.3 | 2.3 | no signal |
| 189 | Eczema | 17 | 2.3 | 2.3 | signal |
| 190 | Pain Of Skin | 9 | 2.3 | 2.3 | signal |
| 191 | Haemorrhage Intracranial | 5 | 2.3 | 2.3 | no signal |
| 192 | Blood Thyroid Stimulating Hormone Increased | 3 | 2.2 | 2.2 | no signal |
| 193 | Ovarian Cancer | 3 | 2.2 | 2.2 | no signal |
| 194 | Injection Site Discolouration | 4 | 2.2 | 2.2 | no signal |
| 195 | Muscle Spasticity | 4 | 2.2 | 2.2 | no signal |
| 196 | Osteonecrosis Of Jaw | 8 | 2.2 | 2.2 | signal |
| 197 | Deformity | 3 | 2.2 | 2.2 | no signal |
| 198 | Tuberculosis | 4 | 2.1 | 2.1 | no signal |
| 199 | Thrombotic Microangiopathy | 3 | 2.1 | 2.1 | no signal |
| 200 | Parkinsonism | 3 | 2.1 | 2.1 | no signal |
| 201 | Malignant Neoplasm Progression | 30 | 2.0 | 2.0 | signal |
| 202 | Psoriasis | 38 | 2.0 | 2.0 | no signal |
| 203 | Femur Fracture | 9 | 2.0 | 2.0 | no signal |
| 204 | Skeletal Injury | 3 | 1.9 | 1.9 | no signal |
| 205 | Gastric Cancer | 7 | 1.9 | 1.9 | no signal |
| 206 | Application Site Pain | 6 | 1.9 | 1.9 | no signal |
| 207 | Product Availability Issue | 6 | 1.8 | 1.8 | no signal |
| 208 | Amenorrhoea | 4 | 1.6 | 1.6 | no signal |
| 209 | Myelosuppression | 8 | 1.6 | 1.6 | no signal |
| 210 | Genital Haemorrhage | 3 | 1.6 | 1.6 | no signal |
| 211 | Hair Texture Abnormal | 3 | 1.5 | 1.5 | no signal |
| 212 | Overdose | 44 | 1.4 | 1.4 | no signal |
| 213 | Dermatitis Atopic | 10 | 1.4 | 1.4 | no signal |
| 214 | Device Failure | 3 | 1.3 | 1.3 | no signal |
| 215 | Needle Issue | 5 | 1.2 | 1.2 | no signal |
| 216 | Drug Dependence | 27 | 1.1 | 1.1 | no signal |
| 217 | Foetal Exposure During Pregnancy | 13 | 1.1 | 1.1 | no signal |
| 218 | Application Site Erythema | 4 | 1.0 | 1.0 | no signal |
| 219 | Product Preparation Error | 3 | 1.0 | 1.0 | no signal |
| 220 | Injection Site Mass | 5 | 0.9 | 0.9 | no signal |
| 221 | Device Leakage | 5 | 0.8 | 0.8 | no signal |
| 222 | Device Dislocation | 5 | 0.8 | 0.8 | no signal |